---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-005271"
form_type: "8-K"
ticker: "IPSC"
cik: "0001850119"
company_name: "Century Therapeutics, Inc."
filed_at: "2024-01-19T23:59:59+00:00"
generated_at: "2026-06-06T21:27:15.248852+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Century Therapeutics CFO Michael Diem resigns; Douglas Carr named interim CFO

## Summary
- CFO Michael C. Diem resigned effective Feb 2, 2024; company has initiated a search for a permanent replacement.
- Douglas Carr, SVP Finance and Operations, will serve as interim principal financial officer following Dr. Diem's departure.
- Dr. Diem's resignation is not due to any disagreement with the company's operations, policies, or practices.

## SEC filing metadata
- accession: 0001104659-24-005271
- form_type: 8-K
- ticker: IPSC
- cik: 0001850119
- company_name: Century Therapeutics, Inc.
- filed_at: 2024-01-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850119/000110465924005271/0001104659-24-005271-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850119/000110465924005271/tm243558d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-005271
- JSON: https://secwatch.observer/filing/0001104659-24-005271.json
- Plain text: https://secwatch.observer/filing/0001104659-24-005271.txt

## Key facts
- Executive change
  Douglas Carr was appointed as interim Principal Financial Officer at Century Therapeutics, Inc..
  - Action: appointed
  - Role: interim Principal Financial Officer
  source text: Following the effectiveness of Dr. Diem’s resignation and until a new Chief Financial Officer is appointed, Douglas Carr, the Company’s Senior Vice President, Finance and Operations, will serve as interim Principal Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850119/000110465924005271/0001104659-24-005271-index.htm
- Executive change
  Michael C. Diem resigned as Chief Financial Officer at Century Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On January 15, 2024, Michael C. Diem, M.D. notified Century Therapeutics, Inc. (the “Company”) of his decision to resign as Chief Financial Officer of the Company, effective as of February 2, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850119/000110465924005271/0001104659-24-005271-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.